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Background: To evaluate the prognostic significance of paranasal sinus invasion for patients with NPC and to
provide empirical proofs for the T-staging category of paranasal sinus invasion according to the AJCC staging
system for nasopharyngeal carcinoma.
Methods: The clinical records and imaging studies of 770 consecutive patients with newly diagnosed, untreated,
and nondisseminated NPC were reviewed retrospectively. The overall survival, distant metastasis-free survival, and
local relapse-free survival of these patients were analyzed using the Kaplan-Meier method, and the differences were
compared using the log-rank test.
Results: The incidence of paranasal sinus invasion was 23.6%, with the rate of incidence of sphenoid sinus invasion
being the highest. By multivariate analysis, paranasal sinus invasion was shown to be an independent prognostic
factor for overall survival, distant metastasis-free survival, and local relapse-free survival (p < 0.05 for all). No significant
differences in overall survival, distant metastasis-free survival, and local relapse-free survival were observed between
patients with sphenoid sinus invasion alone and those with maxillary sinus and ethmoid sinus invasion (p = 0.87,
p = 0.80, and p = 0.37, respectively). The overall survival, distant metastasis-free survival, and local relapse-free survival
for patients with stage T3 disease with paranasal sinus invasion were similar to the survival rates for patients with stage
T3 disease without paranasal sinus invasion (p = 0.22, p = 0.15, and p = 0.93, respectively). However, the rates of overall
survival and local relapse-free survival were better for patients with stage T3 disease with paranasal sinus invasion than
for patients with stage T4 disease (p < 0.01, and p = 0.03, respectively).
Conclusions: Paranasal sinus invasion is an independent negative prognostic factor for NPC, regardless of which sinus
is involved. Our results confirm that it is scientific and reasonable for the AJCC staging system for nasopharyngeal
carcinoma to define paranasal sinus invasion as stage T3 disease.
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Table 1 The characteristics of 770 patients with
nasopharyngeal carcinoma





≥50 years old 255(33.1%)


















IVA ~ IVB 114(14.8%)
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Nasopharyngeal carcinoma (NPC) is endemic in Southeast
Asia, especially in the southern provinces of China [1].
The occurrence of paranasal sinus invasion is not unusual,
with an incidence of nearly 30% based on CT and MRI
findings [2]. Sphenoid sinus invasion is the most common,
followed by maxillary sinus and ethmoid sinus invasion.
The tumor-node-metastasis (TNM) staging system for
malignancies is used to evaluate prognosis, aid treatment
planning, and facilitate the stratification of treatment. At
present, the seventh edition of the American Joint Com-
mittee on Cancer (AJCC) staging system is widely used
throughout the world, and patients with NPC and para-
nasal sinus invasion are defined as stage T3 according to
the staging system [3]. With regard to the prognostic
value of paranasal sinus invasion and its suitable position
in the T staging, there are few literature reports for refer-
ence. Tao et al. developed a prognostic scoring system
(PSS) that could help identify NPC patients with different
risk for locoregional relapse, and found that sphenoid
sinus, ethmoid sinus and maxillary sinus invasion were
classified as different risk groups [4]. While Mao et al.
considered sphenoidal sinus invasion alone had a better
outcome for patients with NPC than did other paranasal
sinus invasion [5]. Both studies indicated that tumor in-
vasion into the different paranasal sinuses might have
different effects on the prognosis of patients with NPC.
On the other hand, the results of Pan et al. revealed that
when paranasal sinus invasion were classified as T3
according the 7th edition AJCC T classification, the
segregation of LRFS curves between stage T3 and T4
groups could be well displayed [6]. Which, in a sense, have
provided evidence and reference for the AJCC T- staging.
In the present staging system for NPC, radiologic ima-
ging, especially MRI, plays an important role. In compa-
rison to CT, MRI, with its superior soft-tissue contrast,
can provide a more accurate definition of early invasion
beyond the nasopharynx and a more accurate assess-
ment of the parapharyngeal space, skull base, paranasal
sinus, and cranial nerve invasion [7-9]. Given these ad-
vantages, MRI is considered the optimal imaging tech-
nique for studying the extension of local disease in NPC.
Therefore, we conducted a retrospective study with a
large sample size to evaluate the prognostic significance
of paranasal sinus invasion for patients with NPC and its
suitable position in the T classification, and thus to pro-
vide more empirical proofs for the AJCC staging system.
Methods
Patient population
This retrospective study was approved by the Institutional
Review Board of Sun Yat-Sen University, Guangzhou,
China. Between December 2003 and December 2005, 782
consecutive patients with newly diagnosed, untreated, andnondisseminated NPC were recruited for this study. Of
the 782 patients, 12 were subsequently eliminated from
the study, including nine patients who were unable to
complete radiation therapy and three patients in whom
new pulmonary nodules and hepatic lesion were detected
when the first course of treatment just started. The re-
maining 770 patients were included in our retrospective
study. The median age of the patients was 44 years (range,
13–75 years), with a male-to-female ratio of 3.3:1. All of
the patients underwent a pretreatment evaluation that
included a complete patient history, physical and neuro-
logic examinations, hematologic and biochemistry pro-
files, whole MR imaging of the neck and nasopharynx,
chest radiography, and abdominal ultrasonography. A
total of 225 patients with stage N2 or N3 disease under-
went emission computed tomography (ECT), and 32 of
the 770 patients (4.2%) underwent positron emission
tomography-CT. The patients’ medical records and ima-
ging studies were analyzed retrospectively, and the NPC
stage was classified according to the seventh edition of the
AJCC staging system [3]. The characteristics of the 770
patients are shown in Table 1.
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All patients underwent MR imaging with a 1.5-T system
(Signa CV/i; GE Healthcare, Chalfont St Giles, England).
The region from the suprasellar cistern to the inferior
margin at the sternal end of the clavicle was examined with
a head-and-neck coil. T1-weighted, fast spin-echo images
in the axial, coronal, and sagittal planes (repetition time
msec/echo time msec, 500–600/10–20) and T2-weighted,
fast spin-echo MR images in the axial plane (4000–6000/
95–110) were obtained before the injection of contrast ma-
terial. After intravenous administration of gadopentetate
dimeglumine (Magnevist; Schering, Berlin, Germany) at a
dose of 0.1 mmol per kilogram of body weight, the axial
and sagittal T1-weighted spin-echo sequences and coronal
T1-weighted fat-suppressed spin-echo sequences were per-
formed sequentially using the same parameters applied
prior to the injection of gadopentetate dimeglumine. A sec-
tion thickness of 5 mm, an intersection gap of 1 mm and a
matrix of 512 × 512 were used.Figure 1 Image of tumor invasion into the sphenoid sinus in patient
revealed that the mass connected with the primary nasopharyngeal lesion
sinus was destroyed.All MR images were reviewed by two radiologists with
more than 10 years of experience in MR imaging of head
and neck cancers. All images were evaluated independ-
ently, and disagreements were resolved by consensus.
Diagnostic MRI criteria for the invasion of the paranasal
sinuses included the following: (1) tumors that had in-
vaded into the sinus cavity connected with a primary
nasopharyngeal lesion and with bone destruction of the
wall of the sinus (Figure 1) and (2) presentation with an
equal or lower signal in the T1WI MRI scan, an equal or
higher signal in the T2WI and an obvious enhancement
in the enhanced MRI scan, with the same signal intensity
characteristics as revealed in the primary lesion [2,10].
Treatment
All patients were treated with definitive-intent radiation
therapy. A total of 618 of the 770 patients (80.2%) under-
went two-dimensional conventional radiation therapy, 115
(14.9%) underwent intensity-modulated radiation therapywith NPC. A contrast enhanced coronal T1-weighted MR image
invaded into the sphenoid sinus and that the floor of the sphenoid
Table 2 Multivariate analysis of prognostic factors for
patients with nasopharyngeal carcinoma




Paranasal sinus involvement <0.01 1.76(1.28.2.42)
Parapharyngeal space extension <0.01 1.95(1.31,2.90)
Intracranial extension <0.01 1.74(1.27,2.40)
N classification 0.02 0.69(0.51,0.93)
Distant metastasis-free survival
Age <0.01 1.75(1.23,2.48)
Paranasal sinus involvement 0.02 1.58(1.08,2.30)
Parapharyngeal space extension 0.04 1.62(1.02,2.58)
Skull base erosion <0.01 2.73(1.45,5.16)
N classification <0.01 0.63(0.44, 0.89)
Local relapse-free survival
Paranasal sinus involvement 0.02 1.91(1.11,3.27)
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formal radiation therapy. Details regarding the radiation
therapy techniques have been reported previously [11-13].
Of the 416 patients with stage III or IV NPC (classified
as stage T3-T4 and/or stage N2-N3), 370 (89%) received
neoadjuvant, concomitant, or adjuvant chemotherapy.
When possible, salvage treatments, including afterload-
ing, surgery, and chemotherapy, were provided in the
event of documented relapse or if the disease persisted.
Follow up
The follow-up period was estimated from the first day of
treatment to either the day of death or the day of the last
examination. Follow up was performed with imaging or cli-
nical assessment. The patients were evaluated at least once
every three months during the first two years; thereafter,
patients were followed up every six months until death.
Statistical analysis
The Statistical Package for Social Sciences 15.0 (SPSS,
Chicago, IL) was used for statistical analysis. The follow-
ing endpoints (interval to the first defining event) were
assessed: overall survival (OS), distant metastasis-free
survival (DMFS), and local relapse-free survival (LRFS).
The actual rates were calculated using the Kaplan-Meier
method, and the differences were compared with the
log-rank test [14]. Multivariate analyses with the Cox
proportional hazards model were used to test independent
significance by the backward elimination of insignificant
explanatory variables [15]. The criterion for statistical sig-
nificance was set at α = 0.05, and p values were based on
two-sided test results.
Results
Incidence of paranasal sinus invasion
The incidence of paranasal sinus invasion was 23.6%
(182 of 770 patients), with invasion of the sphenoid sinus,
maxillary sinus and ethmoid sinus in 162 (21.0%), 86
(11.2%) and 38 (4.9%) of the 770 patients, respectively.
None of the patients had frontal sinus invasion. The inci-
dence of sphenoid sinus invasion was higher than that of
maxillary sinus and ethmoid sinus invasion in patients
with NPC. Of the 162 patients with sphenoid sinus inva-
sion, 89 (54.9%) did not have maxillary sinus and ethmoid
sinus invasion. In contrast, of the 86 patients with maxil-
lary sinus invasion and 38 patients with ethmoid sinus in-
vasion, 69 (80.2%) and 32 (84.2%) also had sphenoid sinus
invasion, respectively. Of the 182 patients with paranasal
sinus invasion, 97 (53.3%) had stage T3 disease, and 85
(46.7%) had stage T4 disease.
Prognosis of patients with paranasal sinus invasion
The median follow-up period was 84 months (range, 3–
120 months). In total, 59 patients (7.6%) developed local-regional failure, 129 patients (16.8%) developed distant
metastases, and 184 patients (23.9%) died. The 5-year
overall survival, distant metastasis-free survival, and local
relapse-free survival rates for the entire patient popula-
tion were 80.2%, 84.7%, and 92.4%, respectively. Signifi-
cant differences were observed between patients without
and with paranasal sinus invasion in overall survival
(84.4% vs 67.2%, P < 0.01), distant metastasis-free survival
(88.4% vs 72.3%, P < 0.01) and local relapse-free survival
(94.0% vs 87.0%, P < 0.01), with better outcomes associ-
ated with patients without paranasal sinus invasion.
The following parameters, which could possibly influ-
ence the prognosis, were included in the Cox proportional
hazards model for multivariate analysis: age (≥50 years
and <50 years), sex, nasal cavity extension, oropharyn-
geal extension, parapharyngeal space extension, skull
base erosion, paranasal sinus extension, hypopharyngeal
extension, orbit extension, masticator space extension,
cranial nerve palsy and intracranial extension, N classi-
fication, use of chemotherapy, radiation therapy tech-
nique. The N classification was treated as ordinary
variable in the multivariate analysis. Using multivari-
ate analysis, paranasal sinus invasion was identified as
an independent prognostic factor for overall survival,
distant metastasis-free survival, and local relapse-free
survival (P < 0.05 for all). The parapharyngeal space ex-
tension and N classification were found to be independent
prognostic factors for both overall survival and distant
metastasis-free survival (Table 2).
T-staging category of paranasal sinus invasion
A total of 182 patients developed paranasal sinus inva-
sion. Owing to the proximity of the floor of the sphenoid
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of patients with maxillary sinus or ethmoid sinus inva-
sion accompanied with sphenoid sinus invasion simultan-
eously, the 182 patients were divided into two groups.
Group 1 was composed of patients with invasion of the
sphenoid sinus alone, without invasion of the maxillary
sinus and ethmoid sinus, and group 2 was composed of
patients with invasion of the maxillary sinus and/or
ethmoid sinus. Of the 182 patients with paranasal sinus
invasion, 89 and 93 had group 1 and group 2 invasion,
respectively. No significant differences in overall sur-
vival, distant metastasis-free survival and local relapse-
free survival were observed between the patients with
group 1 and group 2 invasion (p = 0.87, P = 0.80, and
p = 0.37, respectively, Figure 2).
According to the seventh AJCC staging system, 346
patients belonged to stage T3, of which, 249 did not de-
velop paranasal sinus invasion (T3a) and 97 developed
paranasal sinus invasion (T3b). No significant differences
in overall survival, distant metastasis-free survival and
local relapse-free survival were observed between pa-
tients with T3a and those with T3b (p = 0.22, p = 0.15,
and p = 0.93, respectively). However, the rates of overall
survival and local relapse-free survival were better for
patients with T3b than for patients with stage T4 disease
(p < 0.01, and p = 0.03, respectively) (Figure 3). No sig-
nificant difference in distant metastasis-free survival was
observed between patients with T3b and those with T4
disease (p = 0.10). When paranasal sinus invasion was
classified as stage T3, the segregation of survival curves
between the T3 and T4 groups was clearly displayed.
Discussion
The incidence of paranasal sinus invasion of patients
with NPC
NPC is an aggressive neoplasm, and the spread of the
tumor into the paranasal sinuses occurs relatively fre-
quently. The result of the present study, based on the dataFigure 2 Survival curves of patients with NPC and different paranasal
(B) the distant metastasis-free survival probability, and (C) the local relapse
and patients with maxillary sinus and ethmoid sinus invasion. Group 1 and
alone and with maxillary sinus and ethmoid sinus invasion, respectively.from a large cohort, suggested that the incidence of the
invasion of the paranasal sinus in patients with NPC was
23.6%. The highest rate of incidence was of sphenoid sinus
invasion (21%), followed by maxillary sinus invasion
(11.2%) and ethmoid sinus invasion (4.9%). Chong et al. re-
ported the CT and MRI findings of 114 patients with NPC,
21%, 9% and 4% of those patients were detected with
sphenoid sinus, maxillary sinus and ethmoid sinus invasion,
respectively [2]. While the results of King et al. showed that
the incidence rates of sphenoid sinus, maxillary sinus and
ethmoid sinus invasion were 27%, 5% and 14%, respectively
[16]. Our results are roughly the same as those of Chong
et al., but a little different from those of King et al. For
patients with NPC, the local disease spreads in a stepwise
manner from proximal to distal sites [7]. Tumors of the
roof of the nasopharynx tend to spread directly and super-
iorly into the skull base, where there is no muscle or fascia
to act as a barrier against tumor invasion, as well as to the
floor of the sphenoid sinus, which borders the nasopharynx
roof. Therefore, for most patients with NPC, the primary
tumor originating from the nasopharynx directly destroys
the floor of the sphenoid sinus. This accounts for the high
rate of incidence of sphenoid sinus invasion. Additionally,
the posterior wall of the maxillary sinus is adjacent to the
pterygopalatine fossa and accordingly, tumors extending
anteriorly to the pterygopalatine fossa can easily spread to
the maxillary sinus. In contrast, tumors extending to the
sphenoid sinus or nasal cavity are likely to invade the
ethmoid sinus anteriorly or superiorly.
The prognostic significance of paranasal sinus invasion
for patients with NPC
Our retrospective study, based on large number of cases,
revealed that the invasion of the paranasal sinus was an
independent negative prognostic factor for overall sur-
vival, distant metastasis-free survival, and local relapse-
free survival in patients with NPC. Hence, it is scientific
and reasonable for paranasal sinus invasion to be includedsinus invasion. The graph shows (A) the overall survival probability,
-free survival probability for patients with sphenoid sinus invasion alone
Group 2 represent patients with NPC with sphenoid sinus invasion
Figure 3 Survival curves of patients with NPC with T3 and T4 disease. The graph shows (A) the overall survival probability and (B) the local
relapse-free survival probability for patients with stage T3 and T4 disease according to the seventh AJCC staging system. T3a and T3b represent
patients with T3 disease without and with paranasal sinus invasion, respectively.
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that the maximum primary tumor diameter (MPTD) or
primary tumor volume (PTV) had some effect on the
prognosis of patients with NPC [17-21]. Due to the prox-
imity of the floor of the sphenoid sinus to the roof of the
nasopharynx, and the majority of patients with maxillary
sinus or ethmoid sinus invasion accompanied with sphen-
oid sinus invasion simultaneously, we had speculated that
the primary tumor volume of patients with sphenoid sinus
invasion might be a little smaller than that of patients with
ethmoid sinus and maxillary sinus invasion, making for
somewhat better prognosis for patients. However, the
results showed that the prognostic significances for
both groups were not significantly different. We specu-
late this may be due to the following reasons. First, the
primary treatment modality for patients with NPC was
radiation therapy. With the aid of MRI, the range of
local lesions could be evaluated with greater accuracy
and the target and field could be designed more ration-
ally [22]. Additionally, the improved treatment strat-
egies for T3-4 patients with NPC, including the boost
technique of two-dimensional radiation therapy, IMRT,
and the combination of chemotherapy with radiotherapy,
have dramatically improved the treatment outcome with
respect to loco-regional control [12,23,24]. This may be
the reason why no difference was observed in the LRFS
between patients with sphenoid sinus invasion alone and
those with maxillary sinus and ethmoid sinus invasion.
Second, as for the DMFS rate, we think the possible rea-
son may lie in the fact that the difference of the tumor
volume resulted from the different paranasal sinus inva-
sion may not be significant enough to lead to significant
difference of risks for distant failure. For the reasonsgiven above, it is reasonable to consider paranasal sinus
invasion as a single entity in the TNM classification, re-
gardless of which sinus is involved.
The evidence-based study basis of T-staging category of
paranasal sinus invasion
In the fifth edition of the AJCC staging system for NPC,
patients with paranasal sinus invasion were defined as
T3, and this classification remains in the sixth and the
current seventh edition of the AJCC staging system. While
paranasal sinus invasion is classified as stage T4 disease
according to the Chinese 2008 staging system [25]. Pan
et al. compared the predictive value of both staging
systems for patients with NPC [6]. The results revealed
that for the Chinese 2008 T classification, the 5-year LRFS
rates of T3 and T4 groups did not differ significantly,
while the rates between both groups were remarkably
different according to the 7th edition AJCC T classifica-
tion. The possible reason lie in that when compared to
cranial nerve palsy and intracranial extension, paranasal
sinus invasion maybe occur a little bit earlier, accord-
ingly, the tumor volume may be somewhat smaller,
which possibly makes for a better prognosis. In a sense,
this study demonstrated that it was more suitable for
paranasal sinus invasion to be classified as stage T3.
Our results, based on a large number of samples, fur-
ther confirmed this viewpoint, providing more empirical
proofs for the rationality of the AJCC T staging.
The influence of MRI on patients with NPC
All of the patients in the current study were evalu-
ated by MRI. For the lesions of the paranasal sinus in
patients with NPC, many inflammatory changes overlapped
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ferentiate between the two entities and to define the
inflammation-tumor border. MR imaging, especially T2-
weighted and contrast enhanced MR, can help us to solve
this challenging problem. The inflammatory lesions usu-
ally present high signal intensity on T2-weighted image
and a thin superficial enhancement after contrast ad-
ministration, while the tumors reveal relatively lower
signal intensity on T2-weighted image and solid enhance-
ment with contrast administration. In addition, most im-
portantly, the signal intensity and enhancement pattern
of tumors invading the paranasal sinus are usually in
accordance with those of the primary tumor of the
nasopharynx [2,26,27]. Over the past several decades,
MRI has been used to assess the extent of NPC more
reliably and accurately compared with CT, which has
been shown to influence the stage assignment and disease
prognosis [28-30].Limitations of this study
It should be stressed that because of limited resources,
most of patients (80.2%) in this study were treated with
conventional radiotherapy technique. Recently, intensity-
modulated radiotherapy (IMRT) has gradually replaced
two-dimensional conventional radiotherapy as the primary
radiotherapy technique for NPC and has been reported to
provide encouraging treatment outcome [31-35]. There-
fore, the suitability of the staging system of NPC amid the
changes in therapeutic methods needs continual assess-
ment. As well, the effect of paranasal sinus invasion on
the prognosis and staging of patients with NPC should be
further confirmed by clinic studies.Conclusion
Paranasal sinus invasion is an independent negative prog-
nostic factor for NPC, regardless of which sinus is in-
volved. It is scientific and reasonable for paranasal sinus
invasion to be defined as stage T3 disease, as proposed in
the AJCC staging system. Our study provided some em-
pirical proofs for the AJCC T staging.
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